In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

CVS Caremark, CVS Health’s (NYSE:CVS) pharmacy benefit manager, has been ordered by a federal judge to pay $289.9M in damages ...

CVS Caremark must now shoulder nearly $290 million in damages and penalties after being found complicit in a Medicare Part D ...

CNBC's Jim Cramer said he's optimistic about CVS and explained to investors why he the healthcare company's stock is worth buying ...

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...

Behnke accused CVS Caremark of having since 2010 caused health insurers, such as Aetna, to submit inflated claims to the Centers for Medicare and Medicaid Services (CMS), while pharmacies such as ...

CVS Caremark, the pharmacy benefit management division of Woonsocket, R.I.-based CVS Health, stands accused of improperly reporting Medicare generic drug prices to CMS, according to a STAT report.

DeVaney joined CVS Health in 2005, growing his career across CVS Caremark and Aetna, and most recently leading CVS Caremark sales and account management as president of Employer & Health Plans ...